Topicals with evidence, the actives that don't have it, peels, lasers for skin, and the conditions that resist all of it.
Acne scar treatment in darker skin (Fitzpatrick IV-VI) requires modalities that minimize PIH. RF microneedling and subcision are safest; fractional CO2 carries higher…
Chemical peels treat hyperpigmentation and acne in Fitzpatrick IV-VI skin when acid type and concentration match melanin-rich skin. Mandelic and salicylic acid are…
Lasers can worsen melasma in darker skin via rebound hyperpigmentation and melanocyte activation. Low-fluence QS Nd:YAG toning helps but carries risks. Evidence on safe…
Women lose up to 30% of skin collagen in the first five postmenopausal years. Reviews the evidence on HRT, biostimulators, skin boosters, and energy devices for…
PRP has decades of evidence. Exosomes have zero FDA approvals. PDRN sits between them. Head-to-head on mechanism, evidence, regulation, and realistic expectations for…
PIH is the most common pigment complication after lasers, peels, microneedling, and injectables in skin of color. What the evidence says about prevention, early…
Rosacea in Fitzpatrick IV-VI is often missed because erythema is harder to see. Learn safer diagnosis and treatment choices, including why 1064 nm Nd:YAG is usually…
Melasma is chronic, recurrent, and easy to make worse. The evidence-based stack — sun, topicals, oral tranexamic acid, and the cases where lasers help vs harm.